The Global Egg Freezing And Embryo Banking Market was valued at USD 5.1 billion in 2025 and is estimated to grow at a CAGR of 10.3% to reach USD 13.6 billion by 2035.
Market growth is supported by rising awareness and broader social acceptance of fertility preservation among individuals and couples worldwide. Advancements in cryopreservation technologies have significantly improved storage outcomes, increasing confidence in long-term reproductive planning. At the same time, infertility rates continue to rise globally, creating sustained demand for assisted reproductive solutions. Expansion of fertility clinics, stronger collaboration across healthcare networks, and growing availability of supportive financial programs are further accelerating market adoption. Egg freezing and embryo banking allow individuals to preserve reproductive potential and plan parenthood timelines more flexibly. These solutions are increasingly chosen due to lifestyle changes, medical considerations, and professional commitments that influence reproductive decisions. As reproductive healthcare becomes more patient-centric and technologically advanced, fertility preservation services are transitioning from niche offerings to mainstream medical options, positioning the market for long-term growth across both developed and emerging economies.
The embryo banking segment generated USD 3 billion in 2025 and is expected to grow at a CAGR of 10.2% during 2026-2035. This segment supports long-term reproductive planning by enabling preserved embryos to remain viable for future use, offering higher procedural certainty compared to unfertilized preservation methods. Demand continues to increase among individuals seeking delayed parenthood or undergoing fertility-impacting medical treatments.
The short-term storage segment accounted for 67% share in 2025 and is forecast to grow at a CAGR of 10.2% through 2035. Short-duration storage solutions are widely used during active fertility treatment cycles or temporary medical conditions that affect reproductive health, making this segment a consistent revenue contributor.
Asia-Pacific Egg Freezing and Embryo Banking Market was valued at USD 1.7 billion in 2025 and is experiencing strong market momentum. Growing awareness, shifting family planning timelines, and improving access to assisted reproductive healthcare are contributing to rising demand across the region.
Key companies operating in the Global Egg Freezing and Embryo Banking Market include IVIRMA, Progyny, Monash IVF Group, Shady Grove Fertility, Cryos International, Boston IVF, ReproTech, Genea Pty Limited, RMA Network, Extend Fertility, WINFertility, Ovation Fertility, CCRM Fertility, Spring Fertility, New Hope IVF & Fertility Clinic, and Carrot. Companies in the egg freezing and embryo banking market are strengthening their market position through service expansion, technology investment, and strategic collaborations. Many providers are enhancing cryopreservation protocols to improve storage reliability and clinical outcomes. Expansion of clinic networks and partnerships with healthcare systems is helping improve geographic reach and patient access. Firms are also focusing on transparent pricing models, patient education platforms, and digital engagement tools to improve awareness and trust. Investment in data management and laboratory automation is supporting operational efficiency.
This product will be delivered within 2-4 business days.
Market growth is supported by rising awareness and broader social acceptance of fertility preservation among individuals and couples worldwide. Advancements in cryopreservation technologies have significantly improved storage outcomes, increasing confidence in long-term reproductive planning. At the same time, infertility rates continue to rise globally, creating sustained demand for assisted reproductive solutions. Expansion of fertility clinics, stronger collaboration across healthcare networks, and growing availability of supportive financial programs are further accelerating market adoption. Egg freezing and embryo banking allow individuals to preserve reproductive potential and plan parenthood timelines more flexibly. These solutions are increasingly chosen due to lifestyle changes, medical considerations, and professional commitments that influence reproductive decisions. As reproductive healthcare becomes more patient-centric and technologically advanced, fertility preservation services are transitioning from niche offerings to mainstream medical options, positioning the market for long-term growth across both developed and emerging economies.
The embryo banking segment generated USD 3 billion in 2025 and is expected to grow at a CAGR of 10.2% during 2026-2035. This segment supports long-term reproductive planning by enabling preserved embryos to remain viable for future use, offering higher procedural certainty compared to unfertilized preservation methods. Demand continues to increase among individuals seeking delayed parenthood or undergoing fertility-impacting medical treatments.
The short-term storage segment accounted for 67% share in 2025 and is forecast to grow at a CAGR of 10.2% through 2035. Short-duration storage solutions are widely used during active fertility treatment cycles or temporary medical conditions that affect reproductive health, making this segment a consistent revenue contributor.
Asia-Pacific Egg Freezing and Embryo Banking Market was valued at USD 1.7 billion in 2025 and is experiencing strong market momentum. Growing awareness, shifting family planning timelines, and improving access to assisted reproductive healthcare are contributing to rising demand across the region.
Key companies operating in the Global Egg Freezing and Embryo Banking Market include IVIRMA, Progyny, Monash IVF Group, Shady Grove Fertility, Cryos International, Boston IVF, ReproTech, Genea Pty Limited, RMA Network, Extend Fertility, WINFertility, Ovation Fertility, CCRM Fertility, Spring Fertility, New Hope IVF & Fertility Clinic, and Carrot. Companies in the egg freezing and embryo banking market are strengthening their market position through service expansion, technology investment, and strategic collaborations. Many providers are enhancing cryopreservation protocols to improve storage reliability and clinical outcomes. Expansion of clinic networks and partnerships with healthcare systems is helping improve geographic reach and patient access. Firms are also focusing on transparent pricing models, patient education platforms, and digital engagement tools to improve awareness and trust. Investment in data management and laboratory automation is supporting operational efficiency.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2025
Chapter 5 Market Estimates and Forecast, by Service Type, 2022-2035 ($ Mn)
Chapter 6 Market Estimates and Forecast, by Storage duration, 2022-2035 ($ Mn)
Chapter 7 Market Estimates and Forecast, by Technology, 2022-2035 ($ Mn)
Chapter 8 Market Estimates and Forecast, by Application, 2022-2035 ($ Mn)
Chapter 9 Market Estimates and Forecast, by Age Group, 2022-2035 ($ Mn)
Chapter 10 Market Estimates and Forecast, by Region, 2022-2035 ($ Mn)
Chapter 11 Company Profiles
Companies Mentioned
The companies profiled in this Egg Freezing and Embryo Banking market report include:- Boston IVF
- Carrot
- CCRM Fertility
- Cryos International
- Extend Fertility
- Genea Pty
- IVIRMA
- Monash IVF Group
- New Hope IVF & Fertility Clinic
- Ovation Fertility
- Progyny
- ReproTech
- RMA Network
- Shady Grove Fertility
- Spring Fertility
- WINFertility
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 135 |
| Published | January 2026 |
| Forecast Period | 2025 - 2035 |
| Estimated Market Value ( USD | $ 5.1 Billion |
| Forecasted Market Value ( USD | $ 13.6 Billion |
| Compound Annual Growth Rate | 10.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 17 |
